Invention Grant
- Patent Title: Recombinant deamidated gliadin antigen
-
Application No.: US13692938Application Date: 2012-12-03
-
Publication No.: US09702885B2Publication Date: 2017-07-11
- Inventor: Roger Walker , Yabin Lu , Urvee Desai , Daming Shan
- Applicant: Bio Rad Laboratories, Inc.
- Applicant Address: US CA Hercules
- Assignee: Bio-Rad Laboratories, Inc.
- Current Assignee: Bio-Rad Laboratories, Inc.
- Current Assignee Address: US CA Hercules
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G01N33/68
- IPC: G01N33/68 ; C12N9/10 ; C07K14/415 ; G01N33/564

Abstract:
The present invention provides a method for determining whether a subject is suffering from celiac disease by contacting a sample of bodily fluid from the subject, with an antigen formed from a hexamer of a gliadin fusion protein immobilized on a solid support. The gliadin fusion protein of the antigen includes a recombinant deamidated gliadin linked to a tag such as Glutathione-S transferase (GST) protein. The antigen is prepared by immobilizing the gliadin fusion protein on the solid support. The antigen can further include tissue Transglutaminase (tTG) cross-linked to the gliadin fusion protein. When tTG is present, the tTG and recombinant deamidated gliadin are mixed together prior to immobilization to the solid phase.
Public/Granted literature
- US20130288274A1 RECOMBINANT DEAMIDATED GLIADIN ANTIGEN Public/Granted day:2013-10-31
Information query
IPC分类: